Adcock Faces Possible Antitrust Charges in South Africa

South Africa’s antitrust watchdog has accused pharmaceutical company Adcock Ingram Holdings Ltd. of profiteering from the Covid-19 pandemic, according to people familiar with the matter.

The Competition Commission’s allegations against the company include that it failed to pass on significant pricing benefits and discounts provided by medical-technology company Baxter International Inc. for vital dialysis machines and related drugs during the health crisis, said the people who asked not to be identified as the information isn’t public.

The penalty for such offenses is as much as 10% of annual revenue or more for repeat offenders, the people said. The commission will ...